Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A novel class of 2,3,4-triarylbenzopyrans has been synthesized and were evaluated for their selective estrogen receptor modulation activity and as a therapeutic agent for breast cancer. Among the compounds synthesized, compounds 11a and 12c exhibited 73.91% and 69.24% inhibition as estrogen antagonistic activity, respectively. Compound 12a showed the lowest IC(50) at 6.97 microM against MCF-7 and 11f showed the lowest IC(50) value of 5.6 microM against MDA-MB-231 cell line in spite of their low receptor binding affinity implicating these compounds probably act through ER independent mechanism.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer
Bioorganic & Medicinal Chemistry 2009.0
Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents
Bioorganic & Medicinal Chemistry 2009.0
Syntheses of conformationally restricted benzopyran based triarylethylenes as growth inhibitors of carcinoma cells
Bioorganic & Medicinal Chemistry Letters 2017.0
Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors
Journal of Medicinal Chemistry 2016.0
Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2 H -chromen-2-one derivatives targeting ERα as anti-breast cancer agents
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis and biological evaluation of 4,6-diaryl-2-pyrimidinamine derivatives as anti-breast cancer agents
Bioorganic & Medicinal Chemistry Letters 2018.0
3-Acyl-5-hydroxybenzofuran derivatives as potential anti-estrogen breast cancer agents: A combined experimental and theoretical investigation
Bioorganic & Medicinal Chemistry Letters 2013.0